In a recent study published in the JAMA Network Open, researchers examined temporal dynamics of persistent symptom resolution following acute coronavirus disease 2019 (COVID-19) in the general ...
WALTHAM, Mass.--(BUSINESS WIRE)--AlloVir (Nasdaq: ALVR), a late-clinical stage allogeneic T-cell immunotherapy company, today announced the initiation of a Phase 3 registrational study of posoleucel, ...
BOULDER, Colo.--(BUSINESS WIRE)--Crestone, Inc. (“Crestone”) today announced positive topline results from the Phase 2 clinical trial evaluating CRS3123 in patients with Clostridioides difficile ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback